Telix Pharmaceuticals Limited TLX
Updated: 16 Jun 2026
No signal published yet
We already track Telix Pharmaceuticals and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Telix Pharmaceuticals Limited? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Telix Pharmaceuticals free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
In June 2026, Telix announced the pricing of an upsized $600 million USD convertible bond offering to fund commercial expansion and clinical trials. The company is also awaiting an FDA decision on its brain cancer imaging agent, Pixclara, which is expected by September 11, 2026.
What Firelda Watch includes for Telix Pharmaceuticals Limited
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Telix Pharmaceuticals Limited? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Telix Pharmaceuticals free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more